97 %97% of reported adverse events were mild after yellow fever vaccination.
Kenyafièvre jaunepublished 2023The Lancet. Infectious diseasesPubMeddocument of 7 observations
Explore evidence
Gold tier: mechanically validated evidence, with its primary source.
5 evidence items · page 1 / 1
9 %Fatigue occurred in 9% of participants as an adverse event after yellow fever vaccination.
Kenyafièvre jaunepublished 2023The Lancet. Infectious diseasesPubMeddocument of 7 observations
9 %Myalgia occurred in 9% of participants as an adverse event after yellow fever vaccination.
Kenyafièvre jaunepublished 2023The Lancet. Infectious diseasesPubMeddocument of 7 observations
12 %Headache occurred in 12% of participants as an adverse event after yellow fever vaccination.
Kenyafièvre jaunepublished 2023The Lancet. Infectious diseasesPubMeddocument of 7 observations
6 %Cough occurred in 6% of participants as an adverse event after yellow fever vaccination.
Kenyafièvre jaunepublished 2023The Lancet. Infectious diseasesPubMeddocument of 7 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.